International Stem Cell Corp Share Price OTC Bulletin Board
Equities
ISCO
US4603781026
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2022 | 8.18M 684M | Sales 2023 | 7.79M 651M | Capitalization | 496K 41.47M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 0.61 x |
Net Debt 2022 | 3.53M 295M | Net Debt 2023 | 2.59M 216M | EV / Sales 2023 | 0.4 x |
P/E ratio 2022 |
-4.35
x | P/E ratio 2023 |
-3.79
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 27.91% |
Managers | Title | Age | Since |
---|---|---|---|
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 01/08/01 |
Russell Kern
DFI | Director of Finance/CFO | 38 | 01/08/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Russell Kern
DFI | Director of Finance/CFO | 38 | 01/08/01 |
Paul Maier
BRD | Director/Board Member | 76 | 01/07/01 |
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 01/08/01 |
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- ISCO Stock
- ISCO Stock